People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Healthtech, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Conversio Health, LLC | — | Healthtech | Series B | $39.0M | $157.9M | 2020 |
| Aviacode Inc. | — | Other | Series B | $33.8M | $354.4M | 2014 |
| Lumere, Inc. | — | Other Health Care | Series A | $6.3M | $100.5M | 2019 |
Jesse Bland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jesse Bland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rock Morphis | 2 | 5 |
| Jonathan Phillips | 1 | 14 |
| JOHN R. BURCH, JR. | 1 | 7 |
| Rachel Kern | 1 | 7 |
| James Fitzgerald | 1 | 6 |
| John Burch | 1 | 5 |
| JON PHILLIPS | 1 | 5 |
| Scott Hoch | 1 | 5 |
| Christopher Dooley | 1 | 4 |
| Michael Ramich | 1 | 3 |
| David Jensen | 1 | 3 |
| Patrick Cline | 1 | 3 |
| David McClellan | 1 | 3 |
| Bijan R. Salehizadeh | 1 | 2 |
| Kirk Clove | 1 | 2 |
| Jan Newman | 1 | 2 |
| Eric Meizlish | 1 | 2 |
| Pat Cline | 1 | 2 |
| James Hoxter | 1 | 2 |
| Richard Frank | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.